🔎 Trials Near Me

Utama › Kanser Paru-paru › Illinois › Cicero

Kajian klinikal Kanser Paru-paru di Cicero, IL

17 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Cicero (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Edward Hines Jr VA Hospital, Hines · 4 mi jauh
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi jauh
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Mengambil pesertaFasa 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Umur 70 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Mengambil pesertaFasa 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Hope and Healing Clinical Research, Hinsdale · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07476287

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Mengambil pesertaFasa 2
  • Hope and Healing Clinical Research, Hinsdale · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Mengambil pesertaFasa 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
  • Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
  • Endeavor Health, Elmhurst · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06758401

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
  • Advocate High Tech Medical Park, Palos Heights · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauh
  • Edward Hines Jr VA Hospital, Hines · 4 mi jauh
  • Loyola University Medical Center, Maywood · 5 mi jauh
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

Mengambil pesertaKajian pemerhatian
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Edward Hines Jr VA Hospital, Hines · 4 mi jauh
  • Loyola University Medical Center, Maywood · 5 mi jauh
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • Loyola University Medical Center, Maywood · 5 mi jauh
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Mengambil peserta
  • Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Feb 2026 · NCT02984761

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Mengambil pesertaKajian pemerhatian
  • Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
  • Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jan 2026 · NCT06073431

Kajian Kanser Paru-paru di bandar lain

Kajian lain di Cicero

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.